Smartomica Molecular Tumor Boards Platform ™ is designed to be integrated into regular clinical workflow to equip the physician with possible patient tailored scenarios built upon AI based analysis of existing scientific knowledge and clinical practice.
Smartomica Diagnostics, a dedicated unit of Smartomica, works directly with newly diagnosed cancer patients, advanced cancer patients, and cancer survivors to address highly specific needs through the development and implementation of personalized diagnostic, treatment, and monitoring protocols.
Use of Smartomica Molecular Tumor Boards Platform ™ gives a practical opportunity to navigate your patient through individually designed diagnostic scenario and provide personalized treatment protocols. While dedicated experts are involved in the process, the patient remains under your supervision during the whole journey.
Cut down the time required for a complete and reliable analysis of large quantities of data. Identify the most relevant publications to be used as the result of analytical work.
Text analytical tool aimed to address the text search query in the most precise and time effective matter.
Built for automatic ranking of the research articles in accordance to the quality of both presented study and actual publication.
An automated cloud-based solution for comprehensive genetic data analysis and clinical interpretation.
Built to facilitate hypothesis based approach in research on large sets of biomedical texts.
Smartomica Molecular Tumor Boards Platform ™ is designed for mid-size medical practices and larger hospital systems, facilitating a multidisciplinary approach to cancer care. Our software allows experts involved in the case to effectively collaborate in real time.